The rs6576457 G > A variant in the MKRN3 gene promoter significantly increases the risk of central precocious puberty and lung cancer in Hubei Chinese population
Human Molecular Genetics · 2024
DOI: 10.1093/hmg/ddae131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Feng Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Science and Technology, School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, 122 Luo…. Hauptthemen laut MEDLINE: Lung Neoplasms, Promoter Regions, Genetic, Puberty, Precocious, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Makorin RING finger protein 3 (MKRN3) is a key inhibitor of the hypothalamic–pituitary-gonadal (HPG) axis. The association between MKRN3 gene variants and central precocious puberty (CPP) has been repeatedly examined. In a recent study, MKRN3 has been assigned a role of tumor suppressor in lung carcinogenesis. Therefore, it is hypothesized that MKRN3 may be the link between CPP and lung cancer (LC), and certain MKRN3 gene variants may affect individuals' susceptibility to CPP and LC. The rs12441287, rs6576457 and rs2239669 in the MKRN3 gene were selected as the target variants. Sanger sequencing was applied to genotype them in two sets of case–control cohorts, namely 384 CPP girls and 422 healthy girls, 550 LC patients and 800 healthy controls. The results showed that rs6576457 but not rs12441287 or rs2239669 was significantly associated with the risk of CPP and LC. Their association with CPP risk was further confirmed in the following meta-analysis. Subsequent functional assays revealed that the rs6576457 genotypes were correlated with differentially expressed MKRN3, and the rs6576457 alleles affected the transcription repressor Oct-1 binding affinity to the MKRN3 promoter. Collectively, the MKRN3 gene rs6576457 may participate in the CPP pathology and LC tumorigenesis in the Hubei Chinese population. However, the present findings should be validated in additional investigations with larger samples from different ethnic populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Science and Technology, School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, 122 Luoshi Road, Hongshan District, Wuhan, Hubei 430070, China.
- Institute of WUT-AMU, Wuhan University of Technology, 122 Luoshi Road, Hongshan District, Wuhan, Hubei 430070, China.
- Department of Clinical Laboratory, Wuhan Xinzhou District People's Hospital, 61 Xinzhou Road, Xinzhou District, Wuhan, Hubei 431400, China.
- Department of Laboratory, Maternal and Child Health Hospital of Hubei Province, 745 Wuluo Road, Hongshan District, Wuhan, Hubei 430070, China.
ORCID-Profile: Bifeng Chen
Förderung
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wu, F., Zhou, W., Yue, Z., Deng, X., Kang, W., Yu, Z., Zhang, H., Zhang, B., Feng, X., Xiong, Q., & Chen, B. (2024). The rs6576457 G > A variant in the MKRN3 gene promoter significantly increases the risk of central precocious puberty and lung cancer in Hubei Chinese population. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae131
Vancouver
Wu F, Zhou W, Yue Z, Deng X, Kang W, Yu Z, et al. The rs6576457 G > A variant in the MKRN3 gene promoter significantly increases the risk of central precocious puberty and lung cancer in Hubei Chinese population. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddae131
BibTeX
@article{Wu2024,
author = {Wu, Feng and Zhou, Weiguang and Yue, Zhengchu and Deng, Xiangyuan and Kang, Wenqiang and Yu, Zhiyan and Zhang, Haixia and Zhang, Bixin and Feng, Xianhong and Xiong, Qiantao and Chen, Bifeng},
title = {The rs6576457 G > A variant in the MKRN3 gene promoter significantly increases the risk of central precocious puberty and lung cancer in Hubei Chinese population},
journal = {Human Molecular Genetics},
year = {2024},
doi = {10.1093/hmg/ddae131}
}
EUVIMED